Monday, September 24, 2018

Challenge continues in developing effective drug treatment for Alzheimer's disease

Nilvadipine shows no benefit for the treatment of Alzheimer's disease in mild and moderate stages of the disease, but further studies targeting the early phase of the disease may be warranted.

from Top Health News -- ScienceDaily https://ift.tt/2zrNouF
at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Ozempic may have revealed the brain’s hidden “craving center”

Ozempic-like drugs appear to weaken more than hunger—they may also reduce cravings for alcohol and other addictive substances. Scientists ar...